R. L. Priore

Roswell Park Comprehensive Cancer Center — United States

Medicine · Health Sciences

22h-index1.8kcitations40works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(9), Acute Myeloid Leukemia Research(7), Acute Lymphoblastic Leukemia research(6), Prostate Cancer Diagnosis and Treatment(4), Chronic Lymphocytic Leukemia Research(4)

Publications40 total

RPMIS: The Roswell Park Management Information System
2005· 7 cited
Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials
Multiple Sclerosis Journal·1998· 24 cited
Test-Retest Reliability of the Cognitive Lifetime Drinking History
American Journal of Epidemiology·1997· 86 citedOpen Access
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis
Neurology·1997· 232 cited
Thromboembolism Prophylaxis in Chronic Atrial Fibrillation
Stroke·1997· 111 cited
Bombesin antagonist prevents CO2 laser-induced promotion of oral cancer.
Proceedings of the National Academy of Sciences·1996· 9 citedOpen Access
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients
Multiple Sclerosis Journal·1995· 115 cited
Comparison of Megace, Stilphostrol, Megace Plus DES, or Streptozotocin in Metastatic Prostatic Cancer in Patients With Hormonal Failure and Prior Radiotherapy
The Journal of Urology·1989
Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study
British Journal of Haematology·1989· 27 cited
Comparison of Flutamide and Emcyt in Hormone-Refractory Metastatic Prostatic Cancer
The Journal of Urology·1989
Hormone-Refractory Metastatic Prostate Cancer Treated With Methotrexate, Cyclophosphamide Plus Adriamycin, Cis-Platinum Plus 5-Fluorouracil Plus Cyclophosphamide: National Prostatic Cancer Project Randomized Trial
The Journal of Urology·1989· 1 cited
Comparison of megace, stilphostbol, megace plus des, or streptozotocin in metastatic prostatic cancer in patients with hormonal failure and prior radiotherapy☆
Urology·1988· 5 cited
Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide National prostatic cancer project randomized trial☆
Urology·1988· 28 cited
Comparison of flutamide and emcyt in hormone-refractory metastatic prostatic cancer☆
Urology·1988· 59 cited
Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.
Journal of Clinical Oncology·1987· 90 cited
Pattern of care and follow-up of stages A1, B1 prostatic cancers from multicenter group, the national prostatic cancer Treatment group (NPCTG)
Urology·1987· 1 cited
Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside
Cancer Chemotherapy and Pharmacology·1987· 20 cited
High‐dose cytosine arabinoside in the treatment of preleukemic disorders: A leukemia intergroup study
American Journal of Hematology·1986· 42 cited
Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements
British Journal of Haematology·1986· 38 cited
Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer
Urology·1986· 45 cited
page 1 of 2Next →

Frequent Co-authors

G.P. Murphy(9), Harvey D. Preisler(8), N. Azarnia(6), George P. Browman(5), Hans Grünwald(5), Jack Goldberg(5), Arlan J. Gottlieb(5), G M Shearer(4), Gustavo Cudkowicz(4), Maurice Barcos(4), P. A. Chervenick(4), J R Richert(3), C V Granger(3), D. M. Bartoszak(3), Jonathan Braiman(3), F Munschauer(3), Azra Raza(3), Jeffrey J. Kirshner(3), Investigators of National Prostat(3), James K. Brennan(3)